58-17b-627. Prescription of drugs or devices by a pharmacist.
(1) Beginning January 1, 2022, a pharmacist may prescribe a prescription drug or device if: prescribing the prescription drug or device is within the scope of the pharmacist's training and experience; the prescription drug or device is designated by the division by rule under Subsection; and (3)(a) the prescription drug or device is not a controlled substance that is included in Schedules I, II, III, or IV of: Section; or 58-37-108 the federal Controlled Substances Act, Title II, P.L. 91-513.
(2) Nothing in this section requires a pharmacist to issue a prescription for a prescription drug or device.
(3) The division shall make rules in accordance with, to: Title 63G, Chapter 3, Utah Administrative Rulemaking Act designate the prescription drugs or devices that may be prescribed by a pharmacist under this section, beginning with prescription drugs or devices that address a public health concern that is designated by the Department of Health and Human Services, including: post-exposure HIV prophylaxis; pre-exposure HIV prophylaxis; self-administered hormonal contraceptives; smoking cessation; naloxone; fluoride; vaccines; and epinephrine. create guidelines that a pharmacist must follow when prescribing a prescription drug or device, including guidelines: for notifying the patient's primary care or other health care provider about the prescription; and to prevent the over-prescription of drugs or devices including but not limited to antibiotics; address when a pharmacist should refer the patient to an appropriate health care provider or otherwise encourage the patient to seek further medical care; and implement the provisions of this section.
(4) The division shall make rules under Subsectionin collaboration with: (3) individuals representing pharmacies and pharmacists; individuals representing physicians and advanced practice clinicians; and if the executive director of the Department of Health and Human Services is a physician, the executive director of the Department of Health and Human Services; if the executive director of the Department of Health and Human Services is not a physician, a deputy director who is a physician in accordance with Subsection; or 26B-1-203(4) a designee of the individual described in Section. 26B-1-203
(5) Before November 1 of each year, the division, in consultation with the individuals described in Subsection, shall: (4) develop recommendations for statutory changes to improve patient access to prescribed drugs in the state; and report the recommendations developed under Subsectionto the Health and Human Services Interim Committee. (5)(a)